Cargando…
STE20-type kinase TAOK3 regulates hepatic lipid partitioning
OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD), defined by excessive lipid storage in hepatocytes, has recently emerged as a leading global cause of chronic liver disease. The aim of this study was to examine the role of STE20-type protein kinase TAOK3, which has previously been shown to associ...
Autores principales: | Xia, Ying, Caputo, Mara, Cansby, Emmelie, Anand, Sumit Kumar, Sütt, Silva, Henricsson, Marcus, Porosk, Rando, Marschall, Hanns-Ulrich, Blüher, Matthias, Mahlapuu, Margit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567304/ https://www.ncbi.nlm.nih.gov/pubmed/34634521 http://dx.doi.org/10.1016/j.molmet.2021.101353 |
Ejemplares similares
-
Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring
por: Xia, Ying, et al.
Publicado: (2023) -
Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice
por: Xia, Ying, et al.
Publicado: (2023) -
STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes
por: Caputo, Mara, et al.
Publicado: (2021) -
Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage
por: Anand, Sumit Kumar, et al.
Publicado: (2022) -
Silencing of STE20-type kinase STK25 in human aortic endothelial and smooth muscle cells is atheroprotective
por: Cansby, Emmelie, et al.
Publicado: (2022)